Clinical Trials Browser

Terminated × Carcinoma, Non-Small-Cell Lung × Sorafenib × Clear all

NCT00754923 2019-03-06

Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 2 Terminated

11 enrolled 8 charts

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00543335 2018-11-15

Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00801801 2017-05-17

Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLC

Phase 2 Terminated

5 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

NCT00417248 2016-07-25

Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer

Phase 1/2 Terminated

8 enrolled 4 charts

Carcinoma, Non-Small-Cell Lung

NCT01507740 2015-04-29

Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Liver Neoplasms, Colorectal Neoplasms

NCT00300885 2014-11-04

A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

Phase 3 Terminated

926 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT00558636 2013-12-27

A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

Phase 3 Terminated

91 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung

NCT00473486 2010-01-27

PECASO

Phase 1/2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT00532025 2009-07-28

SIRN

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung